Patent · US Expired

Treatment of diabetes and other symptoms of hypercorticoidism using a synergistic combination of etiocholanolones and estrogen

US4507289A · kind A · utility

10Cited by

0References

20Claims

0Family size

Assignees

Progenics Corporation · US
The Jackson Laboratory · US

Inventors

Douglas L. Coleman · Cranberry Isles, US
Norman Applezweig · New York, US

Key dates

Filing date	Dec 28, 1983
Grant date	Mar 26, 1985
Priority date	—
Expiry date	Dec 28, 2003

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/575
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Diabetes obesity syndromes and associated hypercorticoidism are treated with a synergistic combination of .alpha.- and/or .beta.-etiocholanolone and an estrogen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.